Canakinumab treatment for patients with active recurrent or chronic TNF receptor-associated periodic syndrome (TRAPS): an open-label, phase II study
暂无分享,去创建一个
A. Martini | L. Obici | S. Bhansali | M. Gattorno | H. Lachmann | V. Tormey | K. Abrams | M. Cattalini | A. Speziale | N. Davis